Piyasa Haberleri

En güncel finans ve ekonomi haberlerini, piyasa gelişmelerini, raporları ve analizleri PipVero’da takip edin.

Kaynak: PRNewsWire Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
NREF Announces Second Quarter 2026 Results, Provides Third Quarter 2026 Guidance

NREF Announces Second Quarter 2026 Results, Provides Third Quarter 2026 Guidance

DALLAS, Aug. 6, 2026 /PRNewswire/ -- NexPoint Real Estate Finance, Inc. ("NREF" or the "Company") (NYSE: NREF) today reported its financial results for the quarter ended June 30, 2026. NREF reported net income attributable to common stockholders of $5.4 million, or $0.29 per diluted share1, for the three months ended June 30, 2026.

İlgili Semboller 1
NREF NREF
Kaynak: PRNewsWire
Kaynağı Ziyaret Et
0 0 0
Devamını Oku
Yorum Yap
Kaynak: GlobeNewsWire Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
RedCloud Signs Open Weights and American AI Leadership Letter Alongside Microsoft, NVIDIA and OpenAI

RedCloud Signs Open Weights and American AI Leadership Letter Alongside Microsoft, NVIDIA and OpenAI

RedCloud joins Microsoft, NVIDIA, Meta, OpenAI and others in backing open-weight AI — allowing the Company to specialise advanced models on FMCG trading data inside its own infrastructure, and deliver market-level intelligence without customer data leaving that environment RedCloud joins Microsoft, NVIDIA, Meta, OpenAI and others in backing open-weight AI — allowing the Company to specialise advanced models on FMCG trading data inside its own infrastructure, and deliver market-level intelligence without customer data leaving that environment

İlgili Semboller 1
MSFT Microsoft Corporation
Kaynak: GlobeNewsWire
Kaynağı Ziyaret Et
0 0 0
Devamını Oku
Yorum Yap
Kaynak: Seeking Alpha Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Albemarle: Strong Q2 Earnings, But Not A Buy Yet

Albemarle: Strong Q2 Earnings, But Not A Buy Yet

Albemarle Corporation delivered strong Q2 2026 results, beating revenue and EPS estimates and raising guidance in its Specialties division. ALB generated $638M in free cash flow, reduced capital expenditures by 15%, and improved its balance sheet with significant debt repayment. Lithium demand is set to multiply, driven by both electric vehicles and surging energy storage needs, supporting ALB's long-term growth outlook.

İlgili Semboller 1
ALB ALB
Kaynak: Seeking Alpha
Kaynağı Ziyaret Et
Official Partner ITBFX Start Trading
0 0 0
Devamını Oku
Yorum Yap
Kaynak: GlobeNewsWire Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
AZIO AI Secures Sales Pipeline for 128 NVIDIA HGX B300 Systems

AZIO AI Secures Sales Pipeline for 128 NVIDIA HGX B300 Systems

Initial agreement contemplates the purchase of up to 128 NVIDIA HGX B300 AI systems with an estimated aggregate hardware value of approximately $77 million based on current market pricing, subject to future purchase orders and customary conditions

İlgili Semboller 1
NVDA NVIDIA Corporation
Kaynak: GlobeNewsWire
Kaynağı Ziyaret Et
0 0 0
Devamını Oku
Yorum Yap
Kaynak: PYMNTS Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
ThredUp Navigates K-Shaped Economy as Revenues Climb 17%

ThredUp Navigates K-Shaped Economy as Revenues Climb 17%

Online secondhand marketplace ThredUp is adjusting its marketing tactics while navigating a “K-shaped” economy. The company reported quarterly earnings Wednesday (Aug. 5) showing revenues of $90.8 million, up 17% from the same quarter last year.

İlgili Semboller 1
TDUP TDUP
Kaynak: PYMNTS
Kaynağı Ziyaret Et
0 0 0
Devamını Oku
Yorum Yap
Kaynak: GlobeNewsWire Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
MiNK Therapeutics to Report Second Quarter 2026 Financial Results, Provide Clinical Updates on agenT-797 in Lung Injury, and Highlight Important Business Updates

MiNK Therapeutics to Report Second Quarter 2026 Financial Results, Provide Clinical Updates on agenT-797 in Lung Injury, and Highlight Important Business Updates

NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and immune disorders, today announced that it will report financial results for the second quarter ended June 30, 2026, before the market opens on Thursday, August 13, 2026. The Company will host a conference call and webcast at 8:30 AM ET that morning to review financial results and provide a corporate update focused on the clinical advancement of agenT-797, MiNK's off-the-shelf allogeneic iNKT cell therapy, in acute lung injury.

İlgili Semboller 1
INKT INKT
Kaynak: GlobeNewsWire
Kaynağı Ziyaret Et
0 0 0
Devamını Oku
Yorum Yap
Kaynak: Proactive Investors Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Nasdaq heading lower on earnings falls for AppLovin, Western Digital and SanDisk

Nasdaq heading lower on earnings falls for AppLovin, Western Digital and SanDisk

Wall Street was predicted to see a mixed open on Thursday, as another batch of technology earnings undermines confidence and apparent progress towards an Iran deal raises fears of yet another false dawn. Dow Jones futures were up 57 points, or 0.1%, with the blue-chip index on course to build on the previous session's record close.

İlgili Semboller 1
NDAQ NDAQ
Kaynak: Proactive Investors
Kaynağı Ziyaret Et
0 0 0
Devamını Oku
Yorum Yap
Kaynak: Newsfile Corp Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Kaplan Fox Advises Investors of Alignment Healthcare, Inc. (ALHC) to Contact the Firm Regarding a Securities Investigation

Kaplan Fox Advises Investors of Alignment Healthcare, Inc. (ALHC) to Contact the Firm Regarding a Securities Investigation

New York, New York--(Newsfile Corp. - August 6, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or the "Company") (NASDAQ: ALHC). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are an Alignment Healthcare investor and have suffered losses, or if you have information that could assist in the Alignment Healthcare investigation, you may CLICK HERE to contact us.

İlgili Semboller 1
ALHC ALHC
Kaynak: Newsfile Corp
Kaynağı Ziyaret Et
0 0 0
Devamını Oku
Yorum Yap
Kaynak: Business Wire Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Coincheck Reports Financial Results for First Quarter of Year Ending March 31, 2027

Coincheck Reports Financial Results for First Quarter of Year Ending March 31, 2027

AMSTERDAM--(BUSINESS WIRE)--Coincheck Group N.V. (NASDAQ: CNCK) (“Coincheck Group” or the “Company”), a Dutch public limited liability company that provides digital asset trade execution, custody, staking and asset management services, today reported financial results for the first quarter of the fiscal year ending March 31, 2027 (“fiscal 2027”). References to “fiscal 2026” mean the fiscal year ended March 31, 2026. Financial Highlights:1 Certain Year-Over-Year Highlights Total revenue for the.

İlgili Semboller 1
CNCK CNCK
Kaynak: Business Wire
Kaynağı Ziyaret Et
Official Partner ITBFX Start Trading
0 0 0
Devamını Oku
Yorum Yap
Kaynak: Seeking Alpha Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
MPLX Q2: A Soft-Looking Quarter That Quietly De-Risked The Thesis

MPLX Q2: A Soft-Looking Quarter That Quietly De-Risked The Thesis

MPLX (MPLX) remains a Strong Buy, with reliable income and visible growth supported by robust project execution and strong demand. Distribution coverage remains healthy at ~1.3x, with a 12.5% distribution growth commitment now extended through 2026 and 2027. Recent distributable cash flow softness is attributed to timing and financing of growth projects, not structural weakness, with leverage at a manageable ~3.7x.

İlgili Semboller 1
MPLX MPLX
Kaynak: Seeking Alpha
Kaynağı Ziyaret Et
0 0 0
Devamını Oku
Yorum Yap
Kaynak: Seeking Alpha Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Travere Therapeutics Q2 Earnings: Why I'm Downgrading To Hold (Again)

Travere Therapeutics Q2 Earnings: Why I'm Downgrading To Hold (Again)

Travere Therapeutics is downgraded from Buy to Hold after a >130% rally, reflecting competitive risks and valuation concerns. Filspari's Q2 net sales surged 96% YoY to $141M, but $3B+ peak sales guidance faces new competition in IgAN and FSGS markets. TVTX's pipeline expansion with civorebrutinib and pegtibatinase targets rare kidney and metabolic diseases, but both remain early-stage with uncertain timelines.

İlgili Semboller 1
TVTX TVTX
Kaynak: Seeking Alpha
Kaynağı Ziyaret Et
0 0 0
Devamını Oku
Yorum Yap
Kaynak: PRNewsWire Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
NetEase Cloud Music Inc. to Report First Half 2026 Financial Results on August 20, 2026

NetEase Cloud Music Inc. to Report First Half 2026 Financial Results on August 20, 2026

HANGZHOU, China, Aug. 6, 2026 /PRNewswire/ -- NetEase Cloud Music Inc. (HKEX: 9899 or the "Company"), a leading interactive music streaming service provider in China, today announced that it will report its financial results for the first half year of 2026 ended June 30, 2026 on Thursday, August 20, 2026, after the Hong Kong market closes. The Company's management will host an earnings conference call at 7:00 p.m.

İlgili Semboller 1
NTES NTES
Kaynak: PRNewsWire
Kaynağı Ziyaret Et
0 0 0
Devamını Oku
Yorum Yap